The purpose of the Residency Advisory Committee (RAC) is to provide oversight of the PGY1 program by engaging in an ongoing process of assessment of the residency program.  The committee discusses monthly progress of the residents, initiates program quality improvement, and reviews the biannual feedback from the resident class amongst other activities. 

The RAC comprises of eight PGY1 coordinators and additional pharmacy leaders. Each coordinator helps facilitate their assigned resident's progression and successful completion of the PGY1 program. The coordinators communicate monthly feedback between preceptors, document resident quarterly evaluations, and provide monthly updates at the RAC meeting. 

Here are our members of the Residency Advisory Committee. 

PGY1 Pharmacy Program Director; Clinical Pharmacist, Internal Medicine
Pediatric Clinical Pharmacist; PGY1 Coordinator
Pharmacy Clinical Manager, Clinical and Patient Care Services
Clinical Pharmacist, Cardiology (Valvular and Congenital Heart Diseases); Director, PGY2 Cardiology Pharmacy Residency
Clinical Pharmacist, Bone Marrow Transplant; PGY1 Coordinator
Clinical Pharmacist Practitioner, Infectious Diseases Clinic; PGY1 Coordinator
Manager, Oncology Infusion Pharmacy Operations; PGY1 HSPAL Program Coordinator
Clinical Pharmacist, Population Health; PGY1 Coordinator
Clinical Pharmacist, Cardiology Float; PGY1 Coordinator
Pharmacy Operations Manager, Duke Children's Hospital and Health Center; HSPAL PGY1 Residency Program Coordinator
Clinical Pharmacist, Evening Critical Care
Clinical Hematology/Oncology Pharmacist, Ambulatory Lymphoma; PGY1 Coordinator